Long Non-Coding RNA TRIM52-AS1 Promotes Growth and Metastasis via miR-218-5p/ROBO1 in Hepatocellular Carcinoma

References

• Tang A, Hallouch O, Chernyak V, Kamaya A, Sirlin CB. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis. Abdom Radiol. 2018;43(1):13–25. doi:10.1007/s00261-017-1209-1
   PubMed Web of Science ®Google Scholar
• Cao MQ, You AB, Zhu XD, et al. miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a. J Hematol Oncol. 2018;11(1):12. doi:10.1186/s13045-018-0555-y29361949
   PubMed Web of Science ®Google Scholar
• Sarveazad A, Agah S, Babahajian A, Amini N, Bahardoust M. Predictors of 5 year survival rate in hepatocellular carcinoma patients. J Res Med Sci. 2019;24:86. doi:10.4103/jrms.JRMS_1017_1831741658
   PubMed Web of Science ®Google Scholar
• Pan W, Li W, Zhao J, et al. lncRNA-PDPK2P promotes hepatocellular carcinoma progression through the PDK1/AKT/Caspase 3 pathway. Mol Oncol. 2019;13(10):2246–2258. doi:10.1002/1878-0261.1255331368655
   PubMed Web of Science ®Google Scholar
• Ni W, Zhang Y, Zhan Z, et al. A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1. J Hematol Oncol. 2019;10(1):91. doi:10.1186/s13045-017-0449-4
   Web of Science ®Google Scholar
• Wang Y, Yang L, Chen T, et al. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Mol Cancer. 2019;18(1):28. doi:10.1186/s12943-019-0957-730782188
   PubMed Web of Science ®Google Scholar
• Su K, Zhao Q, Bian A, Wang C, Cai Y, Zhang Y. A novel positive feedback regulation between long noncoding RNA UICC and IL-6/STAT3 signaling promotes cervical cancer progression. Am J Cancer Res. 2018;8(7):1176–1189.30094092
   PubMed Web of Science ®Google Scholar
• Wang H, Huo X, Yang XR, et al. STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4. Mol Cancer. 2017;16(1):136. doi:10.1186/s12943-017-0680-128810927
   PubMed Web of Science ®Google Scholar
• Zhao J, Du P, Cui P, et al. LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer. Oncogene. 2018;37(30):4094–4109. doi:10.1038/s41388-018-0250-z29706652
   PubMed Web of Science ®Google Scholar
• Loewen G, Jayawickramarajah J, Zhuo Y, Shan B. Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol. 2014;7:90. doi:10.1186/s13045-014-0090-425491133
   PubMed Web of Science ®Google Scholar
• Arun G, Spector DL. MALAT1 long non-coding RNA and breast cancer. RNA Biol. 2019;16(6):860–863. doi:10.1080/15476286.2019.159207230874469
   PubMed Web of Science ®Google Scholar
• Feng C, Zhao Y, Li Y, Zhang T, Ma Y, Liu Y. LncRNA MALAT1 promotes lung cancer proliferation and gefitinib resistance by acting as a miR-200a sponge. Arch Bronconeumol. 2019;55(12):627–633. doi:10.1016/j.arbres.2019.03.02631133357
   PubMed Web of Science ®Google Scholar
• Chang J, Xu W, Du X, Hou J. MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS. Onco Targets Ther. 2018;11:3461–3473. doi:10.2147/OTT.S16413129942138
   PubMed Web of Science ®Google Scholar
• Malakar P, Stein I, Saragovi A, et al. Long noncoding RNA MALAT1 regulates cancer glucose metabolism by enhancing mTOR-mediated translation of TCF7L2. Cancer Res. 2018;79(10):2480–2493. doi:10.1158/0008-5472.CAN-18-1432
   Web of Science ®Google Scholar
• Xin X, Wu M, Meng Q, et al. Long noncoding RNA HULC accelerates liver cancer by inhibiting PTEN via autophagy cooperation to miR15a. Mol Cancer. 2018;17(1):94. doi:10.1186/s12943-018-0843-829895332
   PubMed Web of Science ®Google Scholar
• Wang T, Liu J, Li S, Yuan Z, Huang X. Effects of knockout of lincRNA-p21 on the proliferation, migration and invasion ability of HepG2 liver cancer cells. Oncol Lett. 2019;17(6):5103–5107. doi:10.3892/ol.2019.1020131186722
   PubMed Web of Science ®Google Scholar
• Liu J, Xu R, Mai SJ, et al. LncRNA CSMD1-1 promotes the progression of hepatocellular carcinoma by activating MYC signaling. Theranostics. 2020;10(17):7527–7544. doi:10.7150/thno.4598932685003
   PubMed Web of Science ®Google Scholar
• Xu Y, Liu Y, Li Z, et al. Long noncoding RNA H19 is involved in sorafenib resistance in hepatocellular carcinoma by upregulating miR675. Oncol Rep. 2020;44(1):165–173. doi:10.3892/or.2020.760832627034
   PubMed Web of Science ®Google Scholar
• Wu H, Zhong Z, Wang A, et al. LncRNA FTX represses the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via regulating the M1/M2 polarization of Kupffer cells. Cancer Cell Int. 2020;20:266. doi:10.1186/s12935-020-01354-032595415
   PubMed Web of Science ®Google Scholar
• Liu Z, Yan HY, Xia SY, Zhang C, Xiu YC. Downregulation of long non-coding RNA TRIM52-AS1 functions as a tumor suppressor in renal cell carcinoma. Mol Med Rep. 2016;13(4):3206–3212. doi:10.3892/mmr.2016.490826934858
   PubMed Web of Science ®Google Scholar
• Llovet JM, Zucman-Rossi J, Pikarsky E, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016;2:16018.27158749
   PubMed Web of Science ®Google Scholar
• Brown AL, Li M, Goncearenco A, Panchenko AR. Finding driver mutations in cancer: elucidating the role of background mutational processes. PLoS Comput Biol. 2019;15(4):e1006981. doi:10.1371/journal.pcbi.100698131034466
   PubMed Web of Science ®Google Scholar
• Lin Z, Ni X, Dai S, et al. Screening and verification of long noncoding RNA promoter methylation sites in hepatocellular carcinoma. Cancer Cell Int. 2020;20:311. doi:10.1186/s12935-020-01407-432684848
   PubMed Web of Science ®Google Scholar
• Wang C, Chen Y, Chen K, Zhang L. Long noncoding RNA LINC01134 promotes hepatocellular carcinoma metastasis via activating AKT1S1 and NF-kappaB signaling. Front Cell Dev Biol. 2020;8:429. doi:10.3389/fcell.2020.0042932656205
   PubMed Web of Science ®Google Scholar
• Li Y, Li G, Chen X, et al. A novel lncRNA NONHSAT053785 acts as an independent risk factor for intrahepatic metastasis of hepatocellular carcinoma. Onco Targets Ther. 2020;13:5455–5466. doi:10.2147/OTT.S25445532606762
   PubMed Web of Science ®Google Scholar
• Wang Y, Gong G, Xu J, Zhang Y, Wu S, Wang S. Long noncoding RNA HOTAIR promotes breast cancer development by targeting ZEB1 via sponging miR-601. Cancer Cell Int. 2020;20:320. doi:10.1186/s12935-020-01410-932694942
   PubMed Web of Science ®Google Scholar
• Esfandi F, Ghafouri-Fard S, Oskooei VK, Taheri M. Beta-secretase 1 and its naturally occurring anti-sense RNA are down-regulated in gastric cancer. Pathol Oncol Res. 2019;25(4):1627–1633. doi:10.1007/s12253-019-00621-430805871
   PubMed Web of Science ®Google Scholar
• Liu Z, Chen JY, Zhong Y, Xie L, Li JS. lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11. Braz J Med Biol Res. 2019;52(10):e8631. doi:10.1590/1414-431x2019863131531526
   PubMed Web of Science ®Google Scholar
• Li L, Han T, Liu K, Lei CG, Wang ZC, Shi GJ. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway. Eur Rev Med Pharmacol Sci. 2019;23(12):5392–5401. doi:10.26355/eurrev_201906_1820831298392
   PubMed Web of Science ®Google Scholar
• Wu MM, Shen WD, Zou CW, Chen HJ, Guo HM. LncRNA-HEIH suppresses hepatocellular carcinoma cell growth and metastasis by up-regulating miR-199a-3p. Eur Rev Med Pharmacol Sci. 2020;24(11):6031–6038. doi:10.26355/eurrev_202006_2149732572917
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lin S, Yang X, Zhang X. Prognostic and clinicopathological significance of lncRNA MVIH in cancer patients. J Cancer. 2019;10(6):1503–1510. doi:10.7150/jca.2854131031860
   PubMed Web of Science ®Google Scholar
• Ghafouri-Fard S, Esmaeili M, Taheri M, Samsami M. Highly upregulated in liver cancer (HULC): an update on its role in carcinogenesis. J Cell Physiol. 2019;10(6):1503–1510.
   Google Scholar
• Sun Y, Cao FL, Qu LL, Wang ZM, Liu XY. MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1. Eur Rev Med Pharmacol Sci. 2019;23(4):1459–1467. doi:10.26355/eurrev_201902_1710330840267
   PubMed Web of Science ®Google Scholar
• Sanchez Calle A, Kawamura Y, Yamamoto Y, Takeshita F, Ochiya T. Emerging roles of long non-coding RNA in cancer. Cancer Sci. 2018;109(7):2093–2100. doi:10.1111/cas.1364229774630
   PubMed Web of Science ®Google Scholar
• Parikshak NN, Swarup V, Belgard TG, et al. Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism. Nature. 2016;540(7633):423–427. doi:10.1038/nature2061227919067
   PubMed Web of Science ®Google Scholar
• Qi X, Zhang DH, Wu N, Xiao JH, Wang X, Ma W. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015;52(10):710–718. doi:10.1136/jmedgenet-2015-10333426358722
   PubMed Web of Science ®Google Scholar
• Zhou CH, Chen Z, Peng CL, et al. TRIM52-AS1 long noncoding RNA sponges to facilitate hepatocellular carcinoma progression through increasing. Cancer Biother Radiopharm. 2020. doi:10.1089/cbr.2019.3271
   Web of Science ®Google Scholar
• Wang J, Zhou Y, Fei X, et al. Integrative bioinformatics analysis identifies ROBO1 as a potential therapeutic target modified by miR-218 in hepatocellular carcinoma. Oncotarget. 2017;8(37):61327–61337. doi:10.18632/oncotarget.1809928977866
   PubMedGoogle Scholar
• Chen W, Ye L, Wen D, Chen F. MiR-490-5p inhibits hepatocellular carcinoma cell proliferation, migration and invasion by directly regulating ROBO1. Pathol Oncol Res. 2019;25(1):1–9. doi:10.1007/s12253-017-0305-428924964
   PubMed Web of Science ®Google Scholar
• Ao JY, Chai ZT, Zhang YY, et al. Robo1 promotes angiogenesis in hepatocellular carcinoma through the Rho family of guanosine triphosphatases’ signaling pathway. Tumour Biol. 2015;36(11):8413–8424. doi:10.1007/s13277-015-3601-126022159
   PubMedGoogle Scholar